BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gardoni F, Stanic J, Scheggia D, Benussi A, Borroni B, Di Luca M. NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features. Cells 2021;10:E77. [PMID: 33466431 DOI: 10.3390/cells10010077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A, Kumar D, Ambasta RK, Jha NK, Jha SK, Dewanjee S. Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev 2023;85:101838. [PMID: 36610558 DOI: 10.1016/j.arr.2022.101838] [Reference Citation Analysis]
2 Liu C, Lin Y, Zhang X, Peng R, Qiao J. Protective effect of CACNA1A deficiency against seizure in the CACNA1A-CELSR2 digenic knockdown flies.. [DOI: 10.21203/rs.3.rs-2533657/v1] [Reference Citation Analysis]
3 Day C, Silva JP, Munro R, Baker TS, Wolff C, Bithell A, Stephens GJ. Anti-AMPA Receptor Autoantibodies Reduce Excitatory Currents in Rat Hippocampal Neurons. Pharmaceuticals (Basel) 2023;16. [PMID: 36678574 DOI: 10.3390/ph16010077] [Reference Citation Analysis]
4 Ge LL, Xing MY, Zhang HB, Li QF, Wang ZC. Role of nerves in neurofibromatosis type 1-related nervous system tumors. Cell Oncol (Dordr) 2022. [PMID: 36327093 DOI: 10.1007/s13402-022-00723-3] [Reference Citation Analysis]
5 Syed NI. 2021 Editor's Choice Articles in the Section "Cells of the Nervous System". Cells 2022;11. [PMID: 36497062 DOI: 10.3390/cells11233802] [Reference Citation Analysis]
6 Panova MS, Panchenko AS, Ziganshin AM, Mudrov VA. Neurospecific markers of brain damage in infants. Ross vestn perinatol pediatr 2022;67:55-61. [DOI: 10.21508/1027-4065-2022-67-5-55-61] [Reference Citation Analysis]
7 Barake F, Bravo-Zehnder M, González A. Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease. Curr Opin Neurol 2022;35:436-42. [PMID: 35674087 DOI: 10.1097/WCO.0000000000001054] [Reference Citation Analysis]
8 Yonezawa K, Tani H, Nakajima S, Nagai N, Koizumi T, Miyazaki T, Mimura M, Takahashi T, Uchida H. AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and binding. Schizophr Res 2022;243:98-109. [PMID: 35247795 DOI: 10.1016/j.schres.2022.02.033] [Reference Citation Analysis]
9 Luo Y, Li J, Jiang F, Tan A, Qin X, Xiao X, Wang Z, Wang P, Yi Y, Li J, Yuan S, Liu L, Xiao J. Autoimmune Encephalitis With Psychotic Manifestations and Cognitive Impairment Presenting as Schizophrenia: Case Report and Literature Review. Front Psychiatry 2022;13:827138. [DOI: 10.3389/fpsyt.2022.827138] [Reference Citation Analysis]
10 Zhang K, Xu S, Zhou Y, Su T. Case Report: Triphasic Waves in a 9-Year-Old Girl With Anti-NMDAR Encephalitis. Front Neurol 2022;13:819209. [PMID: 35145473 DOI: 10.3389/fneur.2022.819209] [Reference Citation Analysis]
11 Hansen KB, Wollmuth LP, Bowie D, Furukawa H, Menniti FS, Sobolevsky AI, Swanson GT, Swanger SA, Greger IH, Nakagawa T, McBain CJ, Jayaraman V, Low CM, Dell'Acqua ML, Diamond JS, Camp CR, Perszyk RE, Yuan H, Traynelis SF. Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels. Pharmacol Rev 2021;73:298-487. [PMID: 34753794 DOI: 10.1124/pharmrev.120.000131] [Cited by in Crossref: 54] [Cited by in F6Publishing: 66] [Article Influence: 27.0] [Reference Citation Analysis]
12 Italia M, Ferrari E, Di Luca M, Gardoni F. GluA3-containing AMPA receptors: From physiology to synaptic dysfunction in brain disorders. Neurobiol Dis 2021;161:105539. [PMID: 34743951 DOI: 10.1016/j.nbd.2021.105539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Gentile A, D'Acquisto F, Leposavić G. Editorial: The Bidirectional Communication Between Neurons and Immune Cells in the Development of Psychiatric, Neurological and Immune-Mediated Disorders. Front Immunol 2021;12:781151. [PMID: 34691086 DOI: 10.3389/fimmu.2021.781151] [Reference Citation Analysis]
14 Scheggia D, Stanic J, Italia M, La Greca F, Zianni E, Benussi A, Borroni B, Di Luca M, Gardoni F. GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice. Brain Behav Immun 2021:S0889-1591(21)00265-8. [PMID: 34246733 DOI: 10.1016/j.bbi.2021.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Giunta M, Solje E, Gardoni F, Borroni B, Benussi A. Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration. J Exp Pharmacol 2021;13:359-76. [PMID: 33790662 DOI: 10.2147/JEP.S262352] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]